Monteverde, Tiziana

Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma

Muthalagu, N., Monteverde, T., Raffo-Iraolagoitia, X., Wiesheu, R., Whyte, D., Hedley, A., Laing, S., Kruspig, B., Upstill-Goddard, R., Shaw, R., et al. (2020) · Cancer Discovery

Pancreatic and Hepatic Oncology Researchinterferon and immune responses

Cited by 182

Optimizing the Cell Painting assay for image-based profiling

Cimini, B. A., Chandrasekaran, S. N., Kost-Alimova, M., Miller, L., Goodale, A., Fritchman, B., Byrne, P., Garg, S., Jamali, N., Logan, D. J., et al. (2023) · Nature Protocols

Cell Image Analysis TechniquesSingle-cell and spatial transcriptomics

Cited by 177

The ERBB network facilitates KRAS-driven lung tumorigenesis

Kruspig, B., Monteverde, T., Neidler, S., Hock, A., Kerr, E., Nixon, C., Clark, W., Hedley, A., Laing, S., Coffelt, S. B., et al. (2018) · Science Translational Medicine

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 111

Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic Signature

Trapotsi, M.-A., Mouchet, E., Williams, G., Monteverde, T., Juhani, K., Turkki, R., Miljković, F., Martinsson, A., Mervin, L., Pryde, K. R., et al. (2022) · ACS Chemical Biology

Protein Degradation and InhibitorsCell Image Analysis Techniques

Cited by 51

High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS

Ismail, M., Davies, G., Sproat, G., Monteverde, T., Tart, J., Acebrón-García-de-Eulate, M., Gohlke, A., Hancock, D., Adhikari, S., Stefanovic-Barrett, S., et al. (2024) · SLAS Discovery

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling

Cited by 6